|1.||Blau, Nenad: 14 articles (04/2015 - 12/2002)|
|2.||van Spronsen, Francjan J: 14 articles (02/2015 - 10/2004)|
|3.||Wajner, Moacir: 13 articles (12/2015 - 04/2002)|
|4.||MacDonald, Anita: 12 articles (01/2014 - 01/2006)|
|5.||Koch, R: 12 articles (06/2009 - 01/2000)|
|6.||Wolfe, Robert R: 11 articles (12/2014 - 09/2002)|
|7.||Fuchs, Dietmar: 10 articles (02/2015 - 12/2008)|
|8.||Singh, Rani H: 10 articles (01/2015 - 11/2007)|
|9.||Herndon, David N: 10 articles (01/2012 - 09/2002)|
|10.||van Spronsen, F J: 10 articles (01/2011 - 02/2001)|
05/01/2015 - "Phenylalanine-restricted diets have proven effective in treating phenylketonuria. "
09/01/2010 - "Although clinical outcome on a phenylalanine-restricted diet is good, neuropsychological deficits are now known to exist in dietary-treated patients with phenylketonuria, and quality of life, nutritional condition and psychosocial outcome could probably also be improved. "
01/01/1993 - "Inclusion of pteridine data in the discriminant analysis significantly improved the resolution of the classical phenylalanine loading test for the detection of heterozygotes for phenylketonuria."
07/01/1996 - "Main goals of the study are: (1) to find women with phenylketonuria (PKU) and mild untreated hyperphenylalaninaemia (HPA); (2) to inform them about the risks of an untreated pregnancy with PKU and HPA; (3) to evaluate the efficacy of the phenylalanine (Phe) restricted dietary treatment prior to and during pregnancy by following the physical and cognitive development of offspring from treated pregnancies. "
01/01/2013 - "Phenylketonuria (PKU) is caused by a severe phenylalanine hydroxylase deficiency; the mainstay of treatment is a low-phenylalanine diet. "
01/01/2006 - "A displacement study with L-phenylalanine was performed to prove the specificity of tracer tumor uptake, and kinetic modeling was applied to the DPI results. "
12/01/2004 - "The present study investigated the transport mechanism for 3-O-methyl-6-(18)F-fluoro-L-dopa (OMFD), a novel (18)F-labeled phenylalanine derivative, into tumor cells. "
09/01/2015 - "To overcome this limitation of (18)F-FDG, we started to use (4-borono-2- [(18)F]fluoro-L-phenylalanine) (18)F-FBPA, an artificial amino acid tracer which is focusing attention as a tumor specific PET tracer. "
08/15/2015 - "Here we generated and analyzed Pten knock-in mice harboring a C2 domain missense mutation at phenylalanine 341 (Pten(FV)), found in human cancer. "
12/11/2014 - "To explore the potential of KIFC1 as a therapeutic target for human cancers, a series of potent KIFC1 inhibitors featuring a phenylalanine scaffold was developed from hits identified through high-throughput screening (HTS). "
12/01/2003 - "The purpose of this report is to review the obstetric medical, psychological, and nutritional aspects and outcome of the women and offspring enrolled in the Maternal Phenylketonuria Study, which was established to assess the efficacy of a phenylalanine (Phe)-restricted diet in preventing the morbidity associated with this disorder. "
02/01/2000 - "The purpose of this report was to update the results of the Maternal Phenylketonuria Collaborative Study, which was established to assess the efficacy of a phenylalanine-restricted diet in preventing morbidity among the offspring of women with hyperphenylalaninemia. "
07/01/1996 - "The International Maternal Phenylketonuria (PKU) Collaborative Study commenced in 1984 to evaluate the efficacy of the low-phenylalanine diet in reducing the morbidity associated with maternal PKU syndrome. "
02/01/2004 - "The Maternal Phenylketonuria Study was designed to determine the effect of a phenylalanine (Phe)-restricted diet in reducing the morbidity on the fetus. "
04/01/2001 - "Intake of major nutrients by women in the Maternal Phenylketonuria (MPKU) Study and effects on plasma phenylalanine concentrations."
10/01/1989 - "The administration of phenylalanine (Phe) combined with UVA exposure was found to be effective in treating vitiligo. "
01/01/1985 - "The administration of phenylalanine (Phe) combined with UVA exposure was found to be effective in vitiligo. "
12/01/1989 - "Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo."
01/01/1994 - "In order to evaluate the efficacy of L-phenylalanine (L-Phe) in combination with UVA therapy for vitiligo an open trial (149 patients, 18 months) and a small double-blind trial (32 patients, 6 months) were conducted. "
02/13/1998 - "To substantiate this consideration, FT-Raman spectroscopy was utilised to study in vivo total phenylalanine levels at 1004 cm-1 in involved and uninvolved skin of 23 patients with vitiligo, showing in all cases increased levels of phenylalanine in involved compared to uninvolved skin of the same individual. "
|5.||Melanoma (Melanoma, Malignant)
02/01/1961 - "Further observations on the efficacy of phenylalanine mustards against mouse melanoma."
03/01/2003 - "Regional isolated perfusion of extremities for melanoma: now a 26-year experience with drugs other than L-phenylalanine mustard."
04/01/1997 - "Regional isolated perfusion of extremities for melanoma: a 20-year experience with drugs other than L-phenylalanine mustard."
04/01/1992 - "4-Borono-2-[18F]fluoro-D,L-phenylalanine: a possible tracer for melanoma diagnosis with PET."
05/01/1989 - "Regional perfusion of metastatic melanoma of the extremity treated with L-phenylalanine mustard at 40 to 41 degrees C was significantly better than when treated with the drug alone, but some investigations suggest that heat alone may be just as effective. "
|8.||Branched-Chain Amino Acids
|1.||Boron Neutron Capture Therapy
|2.||Drug Therapy (Chemotherapy)
|5.||Vegetarian Diet (Vegetarianism)